Navigation Links
Global Medical Oxygen Systems Industry
Date:9/5/2013

e Analysis for

Medical Oxygen Systems by Product Segment - Oxygen

Concentrators, Liquid Oxygen Systems, Oxygen Cylinders &

Regulators and Oxygen Conserving Devices Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-64

 

Table 48: Russian Historic Review for Medical Oxygen Systems

by Product Segment - Oxygen Concentrators, Liquid Oxygen

Systems, Oxygen Cylinders & Regulators, and Oxygen

Conserving Devices Markets Independently Analyzed with

Annual Sales Figure in US$ Thousand for Years 2004 through

2009 (includes corresponding Graph/Chart) III-65

 

Table 49: Russian 15-Year Perspective for Medical Oxygen

Systems by Product Segment - Percentage Breakdown of Value

Sales for Oxygen Concentrators, Liquid Oxygen Systems,

Oxygen Cylinders & Regulators and Oxygen Conserving Devices

Markets for Years 2004, 2013 & 2018 (includes corresponding

Graph/Chart) III-66

 

4g. REST OF EUROPE III-67

A.Market Analysis III-67

Current & Future Analysis III-67

Product Launches III-67

Strategic Corporate Development III-69

B.Market Analytics III-70

Table 50: Rest of Europe Recent Past, Current & Future

Analysis for Medical Oxygen Systems by Product Segment -

Oxygen Concentrators, Liquid Oxygen Systems, Oxygen

Cylinders & Regulators, and Oxygen Conserving Devices

Markets Independently Analyzed with Annual Sales Figures in

US$ Thousand for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-70

 

Table 51: Rest of Europe Historic Review for Medical Oxygen

Systems by Product Segment - Oxygen Concentrators, Liquid

Oxygen Systems, Oxygen Cylinders & Regulat
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Soligenix to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
2. Global Intravenous Solutions (Parenteral Nutrition) Industry
3. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
4. Lexicon To Present At The Morgan Stanley Global Healthcare Conference
5. Global Cardiac Medical Devices 2009-2015 - Updated Report
6. Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015
7. BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan
8. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
9. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
10. One-Year Data From Global Atrial Fibrillation (AF) Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
11. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... PHILADELPHIA , Aug. 21, 2014  ACI ... platform for independent Data Monitoring Committees. ... to 30 percent over industry standard costs and ... an industry leader in committee services. ... member recruitment and contracting, charter development, statistical programming ...
(Date:8/21/2014)... FLORHAM PARK, N.J. , Aug. 21, 2014 ... specialty pharmacy group purchasing organization (GPO), is pleased ... (Aurora) to collaborate on a host of innovative ... will help Aurora deliver enhanced therapy management services ... Therapy Management (OTM) system. Aurora will ...
(Date:8/21/2014)... 21, 2014  The board of directors of VirtualScopics, ... of clinical trial imaging solutions, today announced that ... officer, effective immediately.  Mr. Groff has held the role ... joined VirtualScopics in January 2006 as an accounting manager ... "When the board of VirtualScopics asked Jim to ...
Breaking Medicine Technology:ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4
... but,Underscore Need for Improved Patient Communication, Lifestyle,Management ... Elevated,Blood Pressure, NEW YORK, May 19, 2007 ... Harris Interactive(R) for the Hypertension Education,Foundation (HEF) ... Inc. (ASH) Twenty-Second Annual Scientific Meeting,and Exposition ...
... SAN FRANCISCO--(BUSINESS WIRE)--May 21, 2007 - Medical,professionals ... problem of,hospital-acquired gram-negative pneumonia may have a ... candidate being,developed by Nektar Therapeutics (Nasdaq:NKTR)., Results ... the use of,NKTR-061 (Inhaled Amikacin) to treat ...
Cached Medicine Technology:Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 2Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 5Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 6Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
(Date:8/22/2014)... somatic mutation at amino acid 918 in the RET ... cell lung cancer (SCLC) tumors and enforced expression of ... signaling and cell growth. , SCLC is a highly ... lung cancers and is strongly associated with tobacco smoking. ... examined for genomic alterations and targeted therapies are approved ...
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... Restore My Vision Today , ... Pearson to help people discover how they can get ... by instead improving their eyesight naturally has caught the ... , “There’s a reason why the glasses and contacts ... because people just assume that it’s their only option ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Testosterone ... filed in U.S. courts on behalf of men ... their use of prescription low testosterone therapies, Bernstein ... new claim was filed against Pfizer Inc. on ... suffered life-threatening heart issues due to his use ...
(Date:8/22/2014)... Wisconsin (PRWEB) August 22, 2014 Mueller ... for Plantar Fasciitis, an exciting new product that provides ... you to stay active while you heal. The package ... is truly a new technology – it is not ... , FasciaDerm® PFTape™ System for Plantar Fasciitis ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... - Transition Therapeutics Inc. ("Transition" or the "Company") ... the first patient has been dosed in a ... with a proprietary Lilly GLP-1 analogue, in patients ... randomized, double-blind, placebo-controlled study in approximately 140 patients ...
... Kan., March 23 According to the National Bureau ... since December 2007 and nearly half of U.S. residents ... Oprah Winfrey replaced her annual ,Favorite Things, holiday show ... Holiday Ever!"However, the $200 billion health & wellness industry ...
... best news that we have been waiting on for the ... through Sinus Dynamics.WESTLAKE VILLAGE, Calif., March 23 Most ENTs ... if it would be better to have a clinical study ... the sinuses. Now this fantastic news and clinical study proves ...
... an industry leader in transportation brokerage for medical and social ... telephony infrastructure. The upgrade will increase simultaneous call volume capability ... ... Louis, MO (PRWEB) March 23, 2009 - Medical Transportation ...
... quality urgent care, serving local Colorado communities from six immediate care ... ... 2009 -- Urgent care provider NextCare ( www.nextcare.com ) announces the ... new locations in Broomfield and Longmont now open and a location ...
... Johnson Foundation (RWJF) and the Plexus Institute (Plexus) today ... Staphylococcus aureus (MRSA) prevention program that employed ... behavioral change, to trigger significant reductions in MRSA incidence ... In addition, as MRSA rates dropped, the hospitals saw ...
Cached Medicine News:Health News:Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 2Health News:Consumers Redefine Value in the Recession: Sauna Sales Prove Preventive Health Is an Essential Investment 2Health News:New Clinical Study News for Treatment of Sinusitis, Sinus Infection and Allergy Sufferers Now Have a New Effective Form of Relief through Sinus Dynamics 2Health News:MTM Upgrades its Phone System to Ensure Leading edge Technology and Software Feature sets for Existing and Future Clients 2Health News:Three New NextCare Immediate Care Clinic Locations Open in Colorado 2Health News:CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent 2Health News:CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent 3
... Designed in collaboration with Dr. George ... the Ojemann Cortical Stimulator is the ... procedures. This portable, constant current unit ... settings suitable for use in the ...
... Integra Epilepsy cortical strip electrodes are ... intracranial placement through a burr hole. ... tunneling and enables quick and secure ... Like all Integra Epilepsy electrode designs, ...
...
... URISYS 2400 is designed for laboratories looking ... and convenience in system operation in terms ... and extended calibration and on-board stability., ... system providing enhanced walk-away capability for medium ...
Medicine Products: